Funder: Crohn's and Colitis Foundation
Due Dates (Anticipated): August 2026: Request Therapeutics Incubator collaboration agreement for redline by applicant's institution deadline (projected) | October 2026: Full proposal / full application submission deadline (including redlined agreement) (projected)
Funding Amounts: Up to $1,500,000 total over 3 years per project; most funding directed to CRO activities, with some possible support for academic partners.
Summary: Supports academic researchers in developing new drug therapies for Crohn’s disease and ulcerative colitis by providing drug discovery resources and collaborative project leadership.
Key Information: Applicants must request the collaboration agreement template before submitting a full proposal; see application process for details.